Immunohistochemical Mdm2 expression in minor salivary gland tumours and its relationship to p53 gene status

Oral Oncology

Volumn 36, Issue 1, 2000, Pages 67-69

  De Araujo V C ^a   Martins, M T ^a   Leite, K R M ^b   Gomez, R S ^c   De Araujo N S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL SÍRIO LIBANÊS   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Mdm2; p53; Salivary gland tumours

Indexed keywords

PROTEIN MDM2; PROTEIN P53;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; EXON; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MINOR SALIVA GLAND; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND TUMOR;

GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MUTATION; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; SALIVARY GLAND NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0344287194     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(99)00054-8     Document Type: Article

References (20)

1. Araujo V.C., Loyola A.M., Pinto D.S. Jr., Borra R.C., Araujo N.S. p53 in biopsies of oral squamous cell carcinoma. A comparative study with a malignancy grading system. European Journal of Cancer. 33B:1997;5-9.
2. Bocklage T., Feddersen R. Unusual mesenchymal and mixed tumors of the salivary gland. An immunohistochemical and flow cytometric analysis of three cases. Archives of Pathology and Laboratory Medicine. 119:1995;69-74.
3. Deguchi H., Hamano H., Hayashi Y. C-myc, ras and p53 expression in pleomorphic adenoma and its malignant form of the human salivary glands. Acta Pathologica Japonica. 43:1993;413-422.
4. Queiroz, L.M.G. Expressão do PCNA, Ki-67, c-erbB-2 e p53 no carcinoma adenóide cístico e adenocarcinoma polimórfico de baixo grau de malignidade de glândula salivar menor. Thesis, São Paulo, 1997.
5. Papadaki H., Finkelstein S.D., Kounelis S., Bakker A., Swalsky P.A., Kapadia S.B. The role of p53 mutation and protein expression in primary and recurrent adenoid cystic carcinoma. Human Pathology. 27:1996;567-572.
6. Jones S.N., Sands A.T., Hancock A.et al. The tumorigenic potential and cell growth characteristics of p53-deficient cells are equivalent in the presence or absence of MDM2. Proceedings of National Academy of Science of United States of America. 93:1996;14 106-14 111.
7. Haupt Y., Maya R., Kazaz A., Oren M. Mdm2 promotes the rapid degradation of p53. Nature. 387:1997;296-299.
8. Kubbutat M.H.G., Jones S.N., Vousden K. Regulation of p53 stability by Mdm2. Nature. 387:1997;299-303.
9. Sun P., Dong P., Dai K., Hannon G.J., Beach D. p53-independent role of MDM2 in TGF-beta1 resistance. Science. 282:1998;2270-2272.
10. Reifenberger G., Liu L., Ichimura K., Schmidt E.E., Collins V.P. Amplification and over-expression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Research. 54:1993;2736-2739.
11. Leach F.S., Tokino T., Meltzer P.et al. p53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Research. 53:1993;2231-2234.
12. McCann A.H., Kirley A., Carney D.N.et al. Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status. British Journal of Cancer. 71:1995;981-985.
13. Kawamata N., Miller C., Levy V., Shintaku I.P., Koeffler H.P., Said J.W. MDM2 oncogene expression in non-Hodgkin's lymphomas. Diagnostic Molecular Pathology. 5:1996;33-38.
14. Pilotti S., Della Torri G., Lavarino C.et al. Distinct MDM2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms. Journal of Pathology. 181:1997;14-24.
15. Seifert G., Brocheriou C., Cardesa A., Eveson J.W., Seifert G. WHO international histological classification of tumours. Tentative histological classification of salivary gland tumours. Pathology, Research and Practice. 186:1990;555-581.
16. Soong R., Iacopetta B.J. A rapid and nonisotopic method for the screening and sequencing of p53 gene mutations in formalin-fixed, paraffin-embedded tumors. Modern Pathology. 10:1997;252-258.
17. Harris C.C., Hollstein M. Clinical implications of the p53 tumor-suppressor gene. New England Journal of Medicine. 28:1993;1318-1327.
18. Ishi K., Nakajima T.T. Evaluation of malignant grade of salivary gland tumours: studies by cytofluorometric nuclear DNA analysis, histochemistry nucleolar organizer regions and immunohistochemistry for p53. Pathology International. 44:1994;287-296.
19. Kärjä V.J., Syrjänen K.J., Kurvinen A.K., Syrjänen S.M. Expression and mutations of p53 in salivary gland tumors. Journal of Oral Pathology and Medicine. 26:1997;217-223.
20. Momand J., Zambetti G.P. MDM-2: "Big Brother" of p53. Journal of Cellular Biochemistry. 64:1997;343-352.